Investors / Frazier Life Sciences / Compare with Longitude Capital

Frazier Life Sciences vs Longitude Capital

Frazier Life Sciences lists 78 portfolio companies and has joined 17 funding rounds; Longitude Capital lists 82 companies and has joined 4 rounds. Frazier Life Sciences comes in most often at Growth (44% of its entries), Longitude Capital comes in most often at Series A (75% of its entries). 9 companies are on both portfolios, among them Airnexis Therapeutics, Alentis Therapeutics and Aptinyx.

Frazier Life SciencesView profilevsLongitude CapitalView profile

78Portfolio companies82

17Funding rounds joined4

6Rounds led1

11Rounds, last 12 months2

$100M or moreTypical round it comes in at$100M or more

0%Sites no longer answering0%

Show as a table

Frazier Life Sciences and Longitude Capital, head to head

	Frazier Life Sciences	Longitude Capital
Portfolio companies	78	82
Funding rounds joined	17	4
Rounds led	6	1
Rounds, last 12 months	11	2
Typical round it comes in at	$100M or more	$100M or more
Sites no longer answering	0%	0%

Companies both back

9

Airnexis Therapeuticsairnexis.comAlentis Therapeuticsalentis.chAptinyxaptinyx.comcAMPfield Therapeuticscampfieldtx.comCollegium Pharmaceuticalcollegiumpharma.comGondolaBiogondolabio.comMirum Pharmaceuticalsmirumpharma.comSierra Oncologysierraoncology.comVaxcytevaxcyte.com

Shared companies are those both firms' own portfolio pages list, each checked against the company's site. The same comparison through the API is POST /v1/overlap, for up to 20 firms. How the data is graded

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/frazierls.com/portfolio

# also
GET /v1/firms/longitudecapital.com/portfolio
GET /v1/firms/frazierls.com/coinvestors